199 related articles for article (PubMed ID: 30760028)
1. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y receptor interactions regulate its mitogenic activity.
Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease.
Paiva SP; Veloso CA; Campos FF; Carneiro MM; Tilan JU; Wang H; Umans JG; Zukowska Z; Kitlinska J
Neuropeptides; 2016 Feb; 55():127-35. PubMed ID: 26431933
[TBL] [Abstract][Full Text] [Related]
5. Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters.
Chatree S; Sitticharoon C; Maikaew P; Uawithya P; Chearskul S
Exp Biol Med (Maywood); 2018 May; 243(9):786-795. PubMed ID: 29763369
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
[TBL] [Abstract][Full Text] [Related]
7. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
Nway NC; Sitticharoon C; Chatree S; Maikaew P
Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y-mediated sex- and afferent-specific neurotransmissions contribute to sexual dimorphism of baroreflex afferent function.
Liu Y; Wu D; Qu MY; He JL; Yuan M; Zhao M; Wang JX; He J; Wang LQ; Guo XJ; Zuo M; Zhao SY; Ma MN; Li JN; Shou W; Qiao GF; Li BY
Oncotarget; 2016 Oct; 7(40):66135-66148. PubMed ID: 27623075
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
[TBL] [Abstract][Full Text] [Related]
12. Development of neuropeptide Y-mediated heart innervation in rats.
Masliukov PM; Moiseev K; Emanuilov AI; Anikina TA; Zverev AA; Nozdrachev AD
Neuropeptides; 2016 Feb; 55():47-54. PubMed ID: 26589184
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
14. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
Guo H; Castro PA; Palmiter RD; Baraban SC
J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Tilan J; Kitlinska J
Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y and receptors are associated with the pyroptosis of nucleus pulposus in aging and degenerative intervertebral discs of rats.
Li F; Xie W; Chen Z; Zhou Z; Wang Z; Xiao J; Li Z
Neuropeptides; 2022 Dec; 96():102284. PubMed ID: 36027700
[TBL] [Abstract][Full Text] [Related]
17. Age related changes of neuropeptide Y-ergic system in the rat duodenum.
Budnik AF; Aryaeva D; Vyshnyakova P; Masliukov PM
Neuropeptides; 2020 Apr; 80():101982. PubMed ID: 31708113
[TBL] [Abstract][Full Text] [Related]
18. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.
Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485
[TBL] [Abstract][Full Text] [Related]
19. Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules.
Stanić D; Mulder J; Watanabe M; Hökfelt T
J Comp Neurol; 2011 May; 519(7):1219-57. PubMed ID: 21452195
[TBL] [Abstract][Full Text] [Related]
20. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Kuo DY; Chen PN; Yu CH; Kuo MH; Hsieh YS; Chu SC
Neuropharmacology; 2012 Oct; 63(5):842-50. PubMed ID: 22732442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]